WO2003029271A3 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides Download PDF

Info

Publication number
WO2003029271A3
WO2003029271A3 PCT/US2002/030474 US0230474W WO03029271A3 WO 2003029271 A3 WO2003029271 A3 WO 2003029271A3 US 0230474 W US0230474 W US 0230474W WO 03029271 A3 WO03029271 A3 WO 03029271A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
novel
present
Prior art date
Application number
PCT/US2002/030474
Other languages
French (fr)
Other versions
WO2003029271A2 (en
Inventor
Tom Y Tang
Jie Zhang
Feiyan Ren
Aidong J Xue
Qing A Zhao
Jian-Rui Wang
Tom Wehrman
Ping Zhou
Malabika Ghosh
Dunrui Wang
Yunqing Ma
Vinod Asundi
Zhiwei Wang
Gezhi Weng
Dana Haley-Vicente
Rodoje T Drmanac
Original Assignee
Nuvelo
Tom Y Tang
Jie Zhang
Feiyan Ren
Aidong J Xue
Qing A Zhao
Jian-Rui Wang
Tom Wehrman
Ping Zhou
Malabika Ghosh
Dunrui Wang
Yunqing Ma
Vinod Asundi
Zhiwei Wang
Gezhi Weng
Dana Haley-Vicente
Rodoje T Drmanac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo, Tom Y Tang, Jie Zhang, Feiyan Ren, Aidong J Xue, Qing A Zhao, Jian-Rui Wang, Tom Wehrman, Ping Zhou, Malabika Ghosh, Dunrui Wang, Yunqing Ma, Vinod Asundi, Zhiwei Wang, Gezhi Weng, Dana Haley-Vicente, Rodoje T Drmanac filed Critical Nuvelo
Priority to AU2002343417A priority Critical patent/AU2002343417A1/en
Priority to CA002461280A priority patent/CA2461280A1/en
Priority to EP02780359A priority patent/EP1430112A4/en
Publication of WO2003029271A2 publication Critical patent/WO2003029271A2/en
Publication of WO2003029271A3 publication Critical patent/WO2003029271A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Abstract

The present invention provides novel nucleic acids, novel polypeptide sequences encoded by the nucleic acids and uses thereof.
PCT/US2002/030474 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides WO2003029271A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002343417A AU2002343417A1 (en) 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides
CA002461280A CA2461280A1 (en) 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides
EP02780359A EP1430112A4 (en) 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32463101P 2001-09-24 2001-09-24
US60/324,631 2001-09-24

Publications (2)

Publication Number Publication Date
WO2003029271A2 WO2003029271A2 (en) 2003-04-10
WO2003029271A3 true WO2003029271A3 (en) 2003-11-20

Family

ID=23264420

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/030474 WO2003029271A2 (en) 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides

Country Status (4)

Country Link
EP (1) EP1430112A4 (en)
AU (1) AU2002343417A1 (en)
CA (1) CA2461280A1 (en)
WO (1) WO2003029271A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394330B2 (en) 2012-03-21 2016-07-19 Alios Biopharma, Inc. Solid forms of a thiophosphoramidate nucleotide prodrug

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
EP1854809B1 (en) 2000-08-22 2012-10-03 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
AU2002230831A1 (en) 2000-10-20 2002-04-29 Millennium Pharmaceuticals, Inc. Compositions of human proteins and method of use thereof
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
MXPA03009510A (en) * 2001-04-17 2005-04-29 Univ Arkansas Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions.
FR2836687A1 (en) 2002-03-04 2003-09-05 Gene Signal GENES INVOLVED IN THE REGULATION OF ANGIOGENESIS, PHARMACEUTICAL PREPARATIONS CONTAINING SAME AND THEIR APPLICATIONS
CA2527571A1 (en) * 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
GB0326197D0 (en) * 2003-11-10 2003-12-17 Randox Lab Ltd Molecular marker
JPWO2005111213A1 (en) * 2004-05-18 2008-03-27 学校法人 久留米大学 Myc target gene mimitin
US7803920B2 (en) 2004-09-29 2010-09-28 Shinya Yamanaka ECAT16 gene expressed specifically in ES cells and utilization of the same
GB0526212D0 (en) * 2005-12-22 2006-02-01 Imp College Innovations Ltd Methods
US7723052B2 (en) 2006-05-11 2010-05-25 Quark Pharmaceuticals, Inc. Screening systems utilizing RTP801
EP2026843A4 (en) 2006-06-09 2011-06-22 Quark Pharmaceuticals Inc Therapeutic uses of inhibitors of rtp801l
ES2421407T3 (en) * 2007-02-09 2013-09-02 Gene Signal Int Sa Wound healing agent and composition
EP1980254A1 (en) * 2007-04-13 2008-10-15 Rijksuniversiteit te Groningen Means and methods for counteracting protein aggregation
WO2009014450A1 (en) * 2007-07-24 2009-01-29 Sanare As Novel peptides with anti-tumor activity
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
JP2013099253A (en) * 2010-03-11 2013-05-23 Intec Systems Institute Inc Diagnostic marker for lung cancer or cervical cancer
US8288334B2 (en) * 2010-06-14 2012-10-16 Gene Signal International Sa Peptides for wound healing
US20130210739A1 (en) * 2010-07-21 2013-08-15 Universite Pierre Et Marie Curie (Paris 6) Bhlh proteins and their use as drugs
CN103209987B (en) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 Substituted nucleotide analog
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc Substituted phosphorothioate nucleotide analogs
NZ630805A (en) 2012-03-22 2016-01-29 Alios Biopharma Inc Pharmaceutical combinations comprising a thionucleotide analog
UA118251C2 (en) 2012-08-23 2018-12-26 Ейдженсіс, Інк. Antibody drug conjugates (adc) that bind to 158p1d7 proteins
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
SI3388075T1 (en) 2015-03-27 2023-10-30 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors (seq id 25 - mrax5-003)
EP4320145A1 (en) * 2021-04-06 2024-02-14 Board of Regents, The University of Texas System Methods and compositions comprising mhc class i peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
US20020150898A1 (en) * 2000-04-18 2002-10-17 Tang Y. Tom Novel nucleic acids and polypeptides
US20030212257A1 (en) * 2001-04-03 2003-11-13 Spytek Kimberly A. Novel human proteins, polynucleotides encoding them and methods of using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 13 February 2001 (2001-02-13), XP002967948, accession no. NCBI Database accession no. (AL532178) *
See also references of EP1430112A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394330B2 (en) 2012-03-21 2016-07-19 Alios Biopharma, Inc. Solid forms of a thiophosphoramidate nucleotide prodrug

Also Published As

Publication number Publication date
EP1430112A2 (en) 2004-06-23
AU2002343417A1 (en) 2003-04-14
CA2461280A1 (en) 2003-04-10
WO2003029271A2 (en) 2003-04-10
EP1430112A4 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
WO2003054152A3 (en) Novel nucleic acids and polypeptides
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2003023013A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2004009834A3 (en) Novel nucleic acids and secreted polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2001079449A3 (en) Novel nucleic acids and polypeptides
WO2003080795A3 (en) Novel nucleic acids and secreted polypeptides
WO2002081517A3 (en) Novel polypeptides and nucleic acids encoded thereby
WO2005049806A3 (en) Novel nucleic acids and polypeptides
WO2001075068A3 (en) Secreted proteins and polynucleotides encoding them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002780359

Country of ref document: EP

Ref document number: 2461280

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2002780359

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002780359

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: JP